|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Amedisys (NASDAQ: AMED) through any online brokerage.
The latest price target for Amedisys (NASDAQ: AMED) was reported by Truist Securities on October 13, 2021. The analyst firm set a price target for 190.00 expecting AMED to rise to within 12 months (a possible 12.17% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Amedisys (NASDAQ: AMED) is $169.38 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Amedisys.
Amedisys’s $Q3 earnings are confirmed for after-market on $November 2, 2021.
There is no upcoming split for Amedisys.
Amedisys is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.